How to treat paediatric infections
Clinicians and health professionals can use our guidelines to manage infections in paediatric patients. We also have guidelines and information from national and international health organisations.
Body system or site of infection | Infection guideline |
---|---|
COVID-19 | |
COVID-19 | |
COVID-19 | Drug interactions with COVID-19 therapies – Liverpool COVID-19 interactions on the University of Liverpool website |
COVID-19 | Queensland statewide COVID-19 guidelines on the Queensland Health website |
Antimicrobial allergies | CHQ-GDL-60011 - Allergic reaction emergency management in children and management of acute anaphylaxis [PDF 570.34 KB] – guideline and flow chart |
Antimicrobial allergies | CHQ-GDL-01076 – Paediatric antibiotic allergy assessment, testing and de-labelling [PDF 924.33 KB] |
Antimicrobial allergies | ASCIA medication allergy – Health care professional resources on the Australasian Society of Clinical Immunology and Allergy website website |
Cardiac infections | |
Cardiac infections | |
Cardiac infections | CHQ-GDL-01066 - Deep cardiac surgical wound infection – mediastinitis suspected [PDF 563.28 KB] |
Cardiac infections | |
Cardiac infections | |
Cardiac infections | CHQ-GDL-01066 - Post cardiac surgery with respiratory focus [PDF 563.28 KB] |
Cardiac infections | Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (3rd edition) on the RHD Australia website |
Refugee health | ASID diagnosis, management and prevention of infections in recently arrived refugees 2016 (abridged version) on the Medical Journal of Australia website |
Parasitic infections | Acanthamoeba (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Amoebiasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Amoebic meningoencephalitis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Ancylostoma caninum (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Ancylostoma duodenale (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Angiostrongyliasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Anisakiasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Ascariasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Babesiosis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Balamuthia mandrillaris (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Balantidiasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Baylisascariasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Blastocystis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Capilliaris (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Chaga's disease (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Clonorchis sinensis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Cryptosporiodosis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Cutaneous Larva Migrans (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Cyclosporiasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Dientamoeba fragilis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Diphyllobothrium latum (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Dracunculus medinensis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Echinococcus (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Entamoeba hystolytica (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Fasciola hepatica (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Filariasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Fluke, hermaphrodytic infection (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Hookworm infection (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Hydatid disease (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Leishmaniasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Lice infestation (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Loa loa (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Microsporiodosis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Naeglaria species (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Necator americanus (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Onchocerca volvulus (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | River blindness (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Roundworm (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Scabies (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Schistosomiasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Sleeping sickness (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Strongyloidiasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Tapeworm infection (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Toxocariasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Toxoplasmosis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Trichinellosis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Trichomoniasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Trypanosomiasis (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | Whipworm (CDC Drugs for Parasitic Infections 2013) on the University of Alabama at Birmingham website |
Parasitic infections | |
Parasitic infections | CHQ-GDL-63401 - Strongyloides and immunosuppressed Children: Screening, management and prophylaxis for Queensland Health staff on the intranet |
Perinatal and congenital infections | ASID Congenital CMV disease – Treatment and management on the ASID SharePoint website |
Perinatal and congenital infections | |
Perinatal and congenital infections | ASID management of perinatal infection – Consensus guideline 2014 on the ASID SharePoint website |
Perinatal and congenital infections | Enterovirus – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Hepatitis B virus – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Hepatitis C virus – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Human immunodeficiency virus (HIV) – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Mycobacterium tuberculosis – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Parvovirus – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Rubella (German measles) – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Streptococcus Group B – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Syphilis in pregnancy (Queensland Health guideline) |
Perinatal and congenital infections | Toxoplasma gondii – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Treponema pallidum (syphilis) – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Listeria – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Varicella zoster virus (VZV) – ASID management of perinatal infections on the ASID SharePoint website |
Perinatal and congenital infections | Herpes simplex virus (HSV) – ASID management of perinatal infections on the ASID SharePoint website |
CNS infections | CHQ-GDL-60818 - Infectious encephalitis: investigation & initial management for Queensland Health staff on the intranet |
CNS infections | CHQ-GDL-01202 - Meningitis (less than 2 months of age) [PDF 628.53 KB] – ED and inpatient wards |
CNS infections | CHQ-GDL-01066 - Meningitis (less than 2 months of age) [PDF 563.28 KB] – PICU |
CNS infections | CHQ-GDL-01202 - Suspected encephalitis (less than 2 months of age) [PDF 628.53 KB] – ED and inpatient wards |
CNS infections | CHQ-GDL-01066 - Suspected encephalitis (less than 2 months of age) [PDF 563.28 KB] – PICU |
CNS infections | CHQ-GDL-01202 - Meningitis (more than 2 months of age) [PDF 628.53 KB] – ED and inpatient wards |
CNS infections | CHQ-GDL-01066 - Meningitis (more than 2 months of age) [PDF 563.28 KB] – PICU |
CNS infections | CHQ-GDL-01202 - Suspected encephalitis (more than 2 months of age) [PDF 628.53 KB] – ED and inpatient wards |
CNS infections | CHQ-GDL-01066 - Suspected encephalitis (more than 2 months of age) [PDF 563.28 KB] – PICU |
CNS infections | |
CNS infections | CHQ-WI-00147 – Audiological monitoring of patients with a history of infection related to hearing loss for Queensland Health staff on the intranet |
CNS infections | CHQ-GDL-01202 - Prophylaxis for neisseria meningitidis (meningococcus) |
CNS infections | Intraventricular dosing of antibiotics – IDSA bacterial meningitis guideline on the Infectious Diseases Society of America website |
CNS infections | Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand on the Wiley website |
CNS infections | Clinical practice guidelines for healthcare-associated ventriculitis and meningitis 2017 on the Infectious Diseases Society of America website |
CNS infections | |
ENT infections | |
ENT infections | CHQ-GDL-60000 - Acute otitis media – Emergency management guideline |
ENT infections | CHQ-GDL-02801 - Management of Post-Tonsillectomy Haemorrhage for Queensland Health staff on the intranet |
ENT infections | CHQ-GDL-00720 - Otitis externa – Emergency management in children [PDF 287.53 KB] |
ENT infections | |
ENT infections | |
ENT infections | |
Eye infections | |
Eye infections | CHQ-GDL-63331 - Neonatal Conjunctivitis: Emergency Management for Queensland Health staff on the intranet |
Gastro-intestinal infections | CHQ-GDL-01202 - Appendicitis – no perforation (uncomplicated) [PDF 628.53 KB] |
Gastro-intestinal infections | |
Gastro-intestinal infections | |
Gastro-intestinal infections | |
Gastro-intestinal infections | |
Gastro-intestinal infections | Peritonitis in a paediatric peritoneal dialysis (CAPD) patient on the Queensland Health website |
Gastro-intestinal infections | |
Gastro-intestinal infections | ASID updated guidelines for the management of clostridium difficile infection in adults and children in Australia and New Zealand on the Wiley website |
Gastro-intestinal infections | CHQ-GDL-01058 - Clostridium difficile (C.difficile) infection [PDF 326.75 KB] |
Gastro-intestinal infections | CHQ-GDL-63001 - Non-typhoidal salmonellosis in children – management guideline |
Gastro-intestinal infections | |
Gastro-intestinal infections | |
Hospital In the Home (HITH) | |
Hospital In the Home (HITH) | Non CF bronchiectasis pulmonary exacerbation – QCH HITH ED pathway [PDF 458.54 KB] |
Hospital In the Home (HITH) | CHQ-GDL-63012 - Cellulitis – QCH HITH ED pathway [PDF 443.46 KB] |
Hospital In the Home (HITH) | CHQ-GDL-63012 - Pre-septal or peri-orbital cellulitis – QCH HITH ED pathway [PDF 443.46 KB] |
Hospital In the Home (HITH) | CHQ-GDL-63012 - Community acquired pneumonia – QCH HITH ED pathway [PDF 443.46 KB] |
Hospital In the Home (HITH) | CHQ-GDL-63012 - Lymphadenitis – QCH HITH ED pathway |
Hospital In the Home (HITH) | CHQ-GDL-63012 - Urinary tract infections – QCH HITH ED pathway [PDF 443.46 KB] |
Hospital In the Home (HITH) | |
Respiratory infections | Paediatric influenza and oseltamivir clinical guideline – Paediatric Improvement Collaborative on the Royal Children's Hospital Melbourne website |
Respiratory infections | Clinical practice guidelines by the Infectious Diseases Society of America: 2018 Update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza on the National Library of Medicine website |
Respiratory infections | |
Respiratory infections | CHQ-GDL-01202 - Community acquired pneumonia (CAP) (less than 1 month of age) [PDF 628.53 KB] – ED and inpatient wards |
Respiratory infections | |
Respiratory infections | CHQ-GDL-01202 - Community acquired pneumonia (CAP) (more than 1 month of age) [PDF 628.53 KB] – ED and inpatient wards |
Respiratory infections | CHQ-GDL-01202 - Community acquired pneumonia (CAP) (unable to tolerate oral antibiotics) [PDF 628.53 KB] – ED and inpatient wards |
Respiratory infections | |
Respiratory infections | CHQ-GDL-01202 - Empyema [PDF 628.53 KB] – ED and inpatient wards |
Respiratory infections | CHQ-GDL-01066 - Severe community acquired pneumonia (severe CAP) [PDF 563.28 KB] – PICU |
Respiratory infections | CHQ-GDL-01066 - Nosocomial or ventilator associated pneumonia [PDF 563.28 KB] – PICU |
Respiratory infections | CHQ-GDL-01202 - Pertussis [PDF 628.53 KB] – ED and inpatient wards |
Respiratory infections | |
Respiratory infections | The Queensland Paediatric Respiratory Syncytial Virus Prevention Program - Nirsevimab |
Respiratory infections | |
Respiratory infections | |
Respiratory infections | |
Respiratory infections | CHQ-GDL-01073 - Cystic fibrosis – Empirical antibiotic management [PDF 613.07 KB] |
Respiratory infections | Non-tuberculous mycobacterium treatment – NTM cystic fibrosis [PDF 613.07 KB] |
Respiratory infections | MRSA pulmonary eradication – Cystic fibrosis [PDF 613.07 KB] |
Respiratory infections | Pseudomonas aeruginosa pulmonary eradication – cystic fibrosis [PDF 613.07 KB] |
Respiratory infections | Burkholderia cepacia (B.cepacia) – cystic fibrosis [PDF 613.07 KB] |
Respiratory infections | |
Respiratory infections | |
Respiratory infections | Pseudomonas aeruginosa pulmonary eradication – non cystic fibrosis bronchiectasis [PDF 458.54 KB] |
Respiratory infections | Azithromycin as anti-inflammatory (non cystic fibrosis bronchiectasis or CSLD) [PDF 458.54 KB] |
Respiratory infections | Treatment of tuberculosis in children and adults on the Queensland Health website |
Respiratory infections | Treatment of tuberculosis in pregnant women and newborn infants on the Queensland Health website |
Respiratory infections | Translated tuberculosis fact sheets for patients on the Queensland Health website |
Respiratory infections | CHQ-GDL-01071 - Respiratory syncytial virus (RSV) prophylaxis – Palivizumab for Queensland Health staff on the intranet |
Respiratory infections | |
Sepsis | Statewide paediatric sepsis pathway on Clinical Excellence Queensland website |
Sepsis | CHQ-GDL-70044 - Sickle cell crisis – Emergency management in children guideline |
Sepsis | CHQ-GDL-01202 - Community acquired sepsis (less than 2 months of age) [PDF 628.53 KB] – ED and inpatient wards |
Sepsis | CHQ-GDL-01202 - Community acquired sepsis (more than 2 months of age) [PDF 628.53 KB] – ED and inpatient wards |
Sepsis | CHQ-GDL-01066 - Community acquired sepsis [PDF 563.28 KB] – PICU |
Sepsis | CHQ-GDL-01066 - Nosocomial sepsis (including CVL sepsis) [PDF 563.28 KB] – PICU |
Sepsis | CHQ-GDL-01066 - Sepsis in immunocompromised host with febrile neutropenia [PDF 563.28 KB] – PICU |
Sepsis | |
Sepsis | |
Sepsis | CHQ-GDL-01249 - Febrile non-neutropenia – oncology [PDF 622.23 KB] |
Sepsis | |
Sepsis | |
Sepsis | |
Sepsis | |
Sepsis | CHQ-GDL-01060 - Taurolidine or citrate lock (taurolock) guideline – CLABSI prevention for CVL, CVAD and PORT for Queensland health staff on the intranet |
Sepsis | |
Sepsis | CHQ-GDL-60819 – Invasive pneumococcal disease : Assessment and initial investigation to exclude immune deficiency guideline for Queensland Health staff on the intranet |
Skeletal, soft tissue and skin infections | |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Severe preseptal cellulitis [PDF 628.53 KB] – inpatients |
Skeletal, soft tissue and skin infections | |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Moderate to severe peri-orbital cellulitis (more than 5 years old and HIB immune) [PDF 628.53 KB] – ED and inpatient wards |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Septic arthritis (more than 5 years old and HIB immune) [PDF 628.53 KB] – ED and inpatient wards |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Osteomyelitis (more than 5 years old and HIB immune) [PDF 628.53 KB] – ED and inpatient wards |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Peri-orbital cellulitis (less than 5 years old and not HIB immune) [PDF 628.53 KB] – ED and inpatient wards |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Septic arthritis (less than 5 years old and not HIB immune) [PDF 628.53 KB] – ED and inpatient wards |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Osteomyelitis (less than 5 years old and not HIB immune) [PDF 628.53 KB] – ED and inpatient wards |
Skeletal, soft tissue and skin infections | |
Skeletal, soft tissue and skin infections | |
Skeletal, soft tissue and skin infections | |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Severe cervical lymphadenitis – inpatients [PDF 628.53 KB] |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Cervical lymphadenitis – outpatients [PDF 628.53 KB] |
Skeletal, soft tissue and skin infections | |
Skeletal, soft tissue and skin infections | |
Skeletal, soft tissue and skin infections | CHQ-GDL-01202 - Animal bites (dog bites) or wounds [PDF 628.53 KB] |
Skeletal, soft tissue and skin infections | CHQ-GDL-01023 - Tetanus prophylaxis in wound management [PDF 501.47 KB] |
Skeletal, soft tissue and skin infections | CHQ-GDL-63000 - Water related wound infections [PDF 181.31 KB] |
Skeletal, soft tissue and skin infections | CHQ-GDL-01066 - Necrotising fasciitis [PDF 563.28 KB] – PICU |
Skeletal, soft tissue and skin infections | CHQ-GDL-01067 - Paediatric bone and Joint infection management [PDF 269.79 KB] |
Skeletal, soft tissue and skin infections | |
Urinary tract infections (UTI) | CHQ-GDL-01066 - Urinary tract infections and pyelonephritis [PDF 563.28 KB] – PICU |
Urinary tract infections (UTI) | CHQ-GDL-01202 - Urinary tract infections and pyelonephritis [PDF 628.53 KB] – ED and inpatient wards |
Fungal infections | |
IV to oral switch | |
Human Immunodeficiency Virus (HIV) and Hepatitis B | CHQ-GDL-65664 - Post exposure prophylaxis for HIV [PDF 283.58 KB] |
Human Immunodeficiency Virus (HIV) and Hepatitis B | CHQ-GDL-65665 - Community acquired needle stick injury [PDF 483.38 KB] |
Human Immunodeficiency Virus (HIV) | |
Human Immunodeficiency Virus (HIV) | Antiretroviral and HIV drug dosing for children and adolescents 2022 – 2023 guideline from the Imperial College Healthcare NHS Trust on the Children's HIV Association website |
Human Immunodeficiency Virus (HIV) | Guidelines for the use of antiretroviral agents in paediatric HIV infection on the Clinical Info HIV website |
Human Immunodeficiency Virus (HIV) | UK HIV guidelines on the Children's HIV Association website |
Human Immunodeficiency Virus (HIV) | HIV drug interactions checker tool on the University of Liverpool website |
Human Immunodeficiency Virus (HIV) | HIV drug resistance database on the Stanford University website |
Human Immunodeficiency Virus (HIV) | Post-exposure prophylaxis (PEP) for HIV guidelines on the ASHM website |
Hepatitis B and C | CHQ-GDL-04794 - Treatment and Management of Viral Hepatitis (B and C). A Multidisciplinary Team Approach for Queensland Health staff on the intranet |
Hepatitis C | Hepatitis C virus (HCV) in children: Australian Commentary on AASLD-IDSA guidance on the ASHM website |
Immunisations and vaccines | Asplenia and hyposplenism paediatric Guidelines for 0 to 18 years on the Spleen Australia website |
Immunisations and vaccines | Immunisation schedules on the Queensland Health website |
Immunisations and vaccines | CHQ-GDL-01221 - Immunisation guideline for medically at risk children guideline for Queensland Health staff on the intranet |
Therapeutic drug monitoring (TDM) | CHQ-PMG-01293 - Paediatric vancomycin therapeutic drug monitoring [PDF 343.32 KB] |
Therapeutic drug monitoring (TDM) | CHQ-PMG-01294 - Paediatric tobramycin and gentamicin therapeutic drug monitoring [PDF 368.53 KB] |
Zoonotic infection | |
Tropical infections | CHQ-PROC-01056 - Assessment and management of malaria in children [PDF 286.34 KB] |
Travel medicine | Assessing fever in the returned traveller on the Australian Prescriber website |
Dental infections | |
Dental infections | |
Dental infections | |
Dental infections | CHQ-GDL-00758 - Facial cellulitis of dental origin [PDF 1522.35 KB] |
Dental infections | |
Dental infections | |
Specialty guidelines | CHQ-GDL-01202 - Paediatric Antibiocard: Empirical Antibiotic Guidelines [PDF 628.53 KB] |
Surgical antibiotic prophylaxis | Eradication of S. aureus nasal colonisation in cardiac surgery patients [PDF 420.24 KB] |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | Adenotonsillectomy and grommet insertion – no prophylaxis required [PDF 420.24 KB] |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | Head, neck or thoracic surgery – prophylaxis [PDF 420.24 KB] |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | ECMO cannulation and decannulation – prophylaxis [PDF 420.24 KB] |
Surgical antibiotic prophylaxis | Cardiac surgery and chest exploration – prophylaxis [PDF 420.24 KB] |
Surgical antibiotic prophylaxis | Cardiac – chest re-cannulation, exploration and closure [PDF 420.24 KB] |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | Upper gastro-intestinal tract (GIT) surgery – prophylaxis [PDF 420.24 KB] |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | Endoscopic procedures – no prophylaxis required [PDF 420.24 KB] |
Surgical antibiotic prophylaxis | Colonoscopic procedures – no prophylaxis required [PDF 420.24 KB] |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | Biliary reconstructive surgery – prophylaxis [PDF 420.24 KB] |
Surgical antibiotic prophylaxis | Gastro-intestinal anastomosis (performed without bowel prep) – prophylaxis [PDF 420.24 KB] |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | Percutaneous transhepatic cholangiogram – prophylaxis [PDF 420.24 KB] |
Surgical antibiotic prophylaxis | Percutaneous endoscopic gastrostomy (PEG) placement – prophylaxis [PDF 420.24 KB] |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | Tenckhoff peritoneal dialysis catheter insertion – prophylaxis [PDF 420.24 KB] |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | Micturating cystourethrogram (MCUG) – prophylaxis [PDF 420.24 KB] |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | Burns and surgical debridement – prophylaxis [PDF 420.24 KB] |
Surgical antibiotic prophylaxis | |
Surgical antibiotic prophylaxis | Mupirocin 2% (Bactroban) nasal ointment to prevent surgical site infection and staphylococcus aureus colonisation [PDF 420.24 KB] – Information for paediatric cardiac surgery patients and families |
Meningococcal bacteraemia (directed treatment and timing of switch) | |
Pneumococcal bacteraemia (without meningitis) (directed treatment and timing of switch) | |
Streptococcus pyogenes (Group A Streptococcus) bacteraemia (directed treatment and timing of switch) | |
Group B Streptococcus bacteraemia (directed treatment and timing of switch) | |
Staphylococcus aureus bacteraemia (directed treatment and timing of switch) | |
Gram-negative bacteraemia (directed treatment and timing of switch) | |
CVC (CVL/CLABSI)-associated bacteraemia (directed treatment and timing of switch) | |
Bacterial meningitis (directed treatment and timing of switch) | |
Brain abscess and subdural empyema (directed treatment and timing of switch) | |
VP shunt infections (directed treatment and timing of switch) | |
Peritonsillar abscess(directed treatment and timing of switch) | |
Retropharyngeal abscess (directed treatment and timing of switch) | |
Mastoiditis (directed treatment and timing of switch) | |
Acute bacterial sinusitis (directed treatment and timing of switch) | |
Acute cervical lymphadenitis (directed treatment and timing of switch) | |
Community-acquired pneumonia (directed treatment and timing of switch) | |
Acute osteomyelitis (directed treatment and timing of switch) | |
Chronic osteomyelitis (directed treatment and timing of switch) | |
Septic arthritis (directed treatment and timing of switch) | |
Pyomyositis (directed treatment and timing of switch) | |
Cellulitis/skin abscesses or boils/surgical site infection (directed treatment and timing of switch) | |
Preseptal (periorbital) cellulitis (directed treatment and timing of switch) | |
Orbital cellulitis (directed treatment and timing of switch) | |
Lower urinary tract infection (UTI/ cystitis) (directed treatment and timing of switch) | |
Pyelonephritis (directed treatment and timing of switch) | |
Epididymitis (directed treatment and timing of switch) |